Cyclodextrins are bucket-shaped oligosaccarides with a hydrophoic cavity and hydrophilic exterior. Given their molecular structure and shape, cyclodextrins function as molecular containers by entrapping guest molecules, such as active pharmaceutical ingredients (APIs), within the internal cavity.

ISP offers a range of cyclodextrins manufactured by Wacker Chemie for pharmacuetical applications. Our alliance with Wacker combines Wacker’s manufacturing expertise and our pharmecuetical technical sales and service to provide solutions to pharmaceutical formulations.
|
Product Name |
Cyclodextrin
Type |
Aqueous Solubility
(g/100ml water @ 25°C) |
Compendial Name |
Monograph Compliance |
USP/NF |
Ph. Eur |
Japan |
Native |
CAVAMAX W6 Pharma |
Alpha |
13 |
Alfadex |

|

|
(JPE)
|
CAVAMAX W7 Pharma |
Beta |
1.7 |
Betadex |

|

|
(JPE)
|
CAVAMAX W8 Pharma |
Gamma |
23 |
Gamma Cyclodextrin |

|
In process |
n/a |
Derivatives |
CAVASOL W7 HP Pharma |
Hydroxy propyl- beta |
158 |
Hydroxypropyl betadex |

|

|
n/a |
CAVITRON W7 HP5 Pharma |
Hydroxy propyl- beta |
158 |
Hydroxypropyl betadex |

|

|
n/a |
CAVITRON W7 HP7 Pharma |
Hydroxy propyl- beta |
239 |
Hydroxypropyl betadex |

|

|
n/a |
n/a= not applicable
The CAVITRON grades of hydroxypropyl- β-Cyclodextrin are manufactured to minimize endotoxin levels and are considered acceptable for use in parenteral applications. The CAVITRON grades of hydroxypropyl- β-Cyclodextrin differ by degree of substitution or average number of hydroxypropyl groups per each cyclodextrin molecule:
Product |
Typical Degree of Substitution |
Molecular Substitution |
CAVASOL W7 HP Pharma |
4.1-5.1 |
0.58-0.73 |
CAVITRON W7 HP5 Pharma |
4.1-5.1 |
0.59-0.73 |
CAVITRON W7 HP7 Pharma |
6.0-8.0 |
0.86-1.14 |
Download CAVAMAX, CAVITRON and CAVASOL Product Overview.
CAVAMAX® and CAVASOL® are registered trademarks of Wacker Chemie AG.